← Back to Screener
Nutriband Inc. Warrant (NTRBW)
Price$0.90
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-75.59%
Price vs S&P 500 (4W)-24.52%
VGM Score23.62
All Metrics
Price vs S&P 500 (YTD)-53.48%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.00M
52-Week Price Return-1.71%
52-Week High$4.50
26-Week Price Return-63.86%
13-Week Price Return-43.75%
3-Month Return Std Dev121.46%
Price vs S&P 500 (52W)-38.66%
Year-to-Date Return-44.10%
5-Day Price Return-10.00%
Month-to-Date Return0.00%
Price vs S&P 500 (13W)-54.61%
Beta2.60x
52-Week Low$0.80
mGradeD
vgmGradeD
Show chart for
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NTRBWNutriband Inc. Warrant | — | — | D | $0.90 |
| ISRGIntuitive Surgical Inc. | F | B | C | $422.06 |
| EWEdwards Lifesciences Corp | D | C | C | $85.96 |
| STESTERIS plc | C | B | C | $212.35 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | C | $87.33 |
| ALGNAlign Technology Inc | B | C | C | $167.74 |
| SNNSmith & Nephew plc | B | C | C | $30.61 |
| MSAMine Safety Incorporated | B | C | C | $161.30 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $74.31 |
| ENOVEnovis Corporation | B | D | C | $23.78 |
| CDRECadre Holdings, Inc. | C | C | D | $30.01 |
About
Nutriband Inc develops transdermal pharmaceutical products designed to prevent opioid abuse, diversion, and misuse. The company's proprietary AVERSA technology incorporates aversive agents into transdermal formulations to discourage drug abuse. Revenue is primarily generated through the sale of consumer transdermal and coated pharmaceutical products.